Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
暂无分享,去创建一个
C. Katlama | J. Gatell | A. Lazzarin | B. Grinsztejn | B. Nguyen | D. Vittecoq | Charles J. Gonzalez | Joshua Chen | Charlotte M. Harvey | R. Isaacs